Practice Location

3334 CAPITAL MEDICAL BLVD
TALLAHASSEE, FL 32308-8405

Phone: (850) 877-8174

What does DAVID BERG research?

Dr. Berg studies Parkinson's disease, looking into how environmental factors and genetics influence its risk and progression. His research also examines lifestyle changes, like diet and exercise, that can help patients manage their condition effectively. Beyond Parkinson’s, he investigates how treatments such as deep brain stimulation and focused ultrasound affect brain health and recovery. He is also interested in the role of gut bacteria in neurological conditions and how exercise affects early signs of Parkinson's disease.

Key findings

  • In a study of 1,051 older adults, 23 were diagnosed with Parkinson's disease 5.3 years after being observed, with slower turning speeds indicating a higher risk of future diagnosis.
  • In a survey of 107 Parkinson's patients, 85% reported making lifestyle changes, and 94% wanted more education on managing their condition.
  • The use of tenecteplase for stroke treatment reduced wait times from 28 to 23 minutes compared to alteplase.
  • Researchers found that moderate exercise improved movement in mice with early Parkinson's disease while intense exercise also reduced anxiety but increased concerning brain activity.
  • Differences in gut bacteria were found in Parkinson's patients, with more harmful bacteria and fewer beneficial types, indicating a potential link to disease development.

Frequently asked questions

Does Dr. Berg study Parkinson's disease?
Yes, Dr. Berg focuses on various aspects of Parkinson's disease, including its causes, treatment, and the impact of lifestyle changes for patients.
What treatments has Dr. Berg researched?
He has researched deep brain stimulation and magnetic resonance-guided focused ultrasound as treatments for brain conditions, assessing their effects on brain health.
Is Dr. Berg's work relevant for patients with early Parkinson's disease?
Absolutely, his studies on exercise and early detection methods provide valuable insights for patients in the early stages of Parkinson's disease.
What impact does lifestyle have on Parkinson's disease according to Dr. Berg's research?
His research shows that lifestyle factors, like exercise and diet, can significantly affect the management and progression of Parkinson's disease.
How does Dr. Berg's research benefit stroke patients?
By exploring quicker treatment options, such as switching medications, his findings aim to improve the outcomes and recovery times for patients experiencing strokes.

Publications in plain English

Impact of lifestyle factors on quantitative motor and cognitive performance: insights from a longitudinal study on healthy ageing.

2026

GeroScience

Zimmermann M, Sünkel U, Wurster I, Lerche S, Hobert MA +9 more

Plain English
This study looked at how lifestyle choices impact physical and mental abilities as we age, focusing on 744 older adults over 8 years. Researchers found that those who engaged in regular exercise, ate a plant-based diet, and had higher education levels maintained better cognitive skills, showing little decline over the years. Specifically, individuals with these healthy habits had consistently better cognitive test scores, demonstrating that making positive lifestyle changes can help older adults stay mentally sharp and independent. Who this helps: This benefits older adults and their caregivers by promoting healthier aging.

PubMed

The Management of Parkinson's Disease Before, during and after Pregnancy-an MDS Scientific Issues Committee Review.

2026

Movement disorders clinical practice

Lehn AC, Lee JY, Sciacca G, Patterson S, Morton A +14 more

Plain English
The study focused on the challenges women with early-onset Parkinson's disease face during pregnancy and the postpartum period, highlighting the lack of established guidelines for managing their care. Key findings include the recommendation that the medication levodopa is the safest during pregnancy, and that women should have individualized care plans for both motor and non-motor symptoms. This research is important because it offers practical advice to help navigate the complex medical decisions surrounding pregnancy for women with Parkinson's disease. Who this helps: This helps women with Parkinson's disease, their families, and healthcare providers.

PubMed

Activation of the alpha 7 nicotinic acetylcholine receptor (CHRNA7) limits hypoxia-induced inflammatory responses and regulates collagens in cultured human granulosa cells†.

2026

Biology of reproduction

Seßenhausen P, Caban KM, Schneider M, Eubler K, Kreitmair N +8 more

Plain English
This study looked at a specific receptor in human ovarian cells called the alpha 7 nicotinic acetylcholine receptor (CHRNA7) to see how it responds to low oxygen levels, which can cause inflammation. Researchers found that activating this receptor reduced inflammation markers, such as IL6 and IL1B, indicating a protective effect. Additionally, activating CHRNA7 changed the levels of various proteins, including some collagens that could be important for egg quality. Who this helps: This research benefits patients undergoing fertility treatments by improving our understanding of egg cell function and health.

PubMed

Longitudinal Blood-Biomarker-Based Assessment of Brain Injury in Patients Undergoing Deep Brain Stimulation and Magnetic Resonance-Guided Focused Ultrasound.

2026

Movement disorders : official journal of the Movement Disorder Society

Dargvainiene J, Helmers AK, Naumann J, Gless CA, Möller B +8 more

Plain English
This study looked at how two treatments for brain conditions, deep brain stimulation (DBS) and magnetic resonance-guided focused ultrasound (MRgFUS), affect brain cells over time. Researchers found that a specific blood marker indicating brain injury (called sNfL) peaked 7 days after treatment, while another marker (sGFAP) peaked within 24 hours, with the highest levels in DBS patients. These findings suggest that monitoring these biomarkers can help determine the best time to evaluate patient recovery after treatment. Who this helps: This benefits patients undergoing DBS or MRgFUS, as well as their doctors in assessing recovery.

PubMed

Turning Slowly Predicts Future Diagnosis of Parkinson's Disease: A Decade-Long Longitudinal Analysis.

2026

Annals of neurology

Elshehabi M, Hansen C, Hobert MA, von Thaler AK, Brockmann K +5 more

Plain English
This study looked at how people turn while walking to see if it could help predict the future onset of Parkinson's disease. Researchers tracked 1,051 older adults over ten years, finding that 23 of them were diagnosed with Parkinson's about 5.3 years after their initial assessment. They discovered that slower turning speeds were linked to a higher likelihood of developing Parkinson's, with notable changes appearing nearly nine years before diagnosis. Who this helps: This benefits patients by allowing earlier detection of Parkinson’s disease.

PubMed

Converting green into good: Pathways from green building practices to social well-being.

2026

Journal of environmental management

Saqib ZA, Ikram M, Berg D

Plain English
This study looked at how green building practices—such as using less water, managing waste better, and using sustainable materials—affect people's well-being in cities. Researchers analyzed data from 585 homes and found that strong management can greatly improve social well-being, indicating that effective leadership in green initiatives is key to achieving better outcomes for residents. This matters because improving people's quality of life in urban areas can contribute to broader goals of health and sustainability. Who this helps: This helps city planners, building managers, and residents.

PubMed

Preventive measures for Parkinson's disease: insights into motivation and barriers from the patients' perspective.

2026

BMC neurology

Haas J, Rogge A, Otto B, Michel N, Berg D +1 more

Plain English
This study looked at how patients with Parkinson's disease (PD) view lifestyle changes, like diet and exercise, as a way to manage their condition. It involved 107 patients, where 85% reported making lifestyle changes and 94% felt education on these changes was important. Many patients were interested but faced challenges like losing motivation, lack of knowledge, and physical limitations, showing that structured support programs could help them maintain these healthy habits. Who this helps: This helps Parkinson's disease patients who want to improve their health through lifestyle changes.

PubMed

Addressing Gaps in Parkinson's Disease Etiology: The Need for a Polyexposure Score.

2026

Movement disorders : official journal of the Movement Disorder Society

Okubadejo NU, Schaeffer E, Noyce AJ, Heinzel S, Burn DJ +3 more

Plain English
This study looks at how different environmental factors and genetics together influence the risk and progression of Parkinson's disease. Researchers emphasize the need for better ways to measure these combined effects, suggesting a new score that could quantify the overall impact of various exposures over a person's life. Improving our understanding of these factors is crucial for developing better predictions, preventive strategies, and tailored treatments for Parkinson's disease. Who this helps: This benefits patients with Parkinson's disease and their doctors.

PubMed

Amyloid-related imaging abnormalities (ARIA) in Alzheimer's disease: from pathophysiology to individualized risk assessment.

2026

Alzheimer's research & therapy

Merkel J, Perneczky R, Jessen F, Frölich L, Jansen O +4 more

PubMed

American Association of Neurological Surgeons/Congress of the Neurological Surgeons Section on Tumors Guidelines: Assessing Their Impact on Brain Tumor Clinical Practice.

2025

Neurosurgery

Robertson FC, Nahed BV, Barkhoudarian G, Veeravagu A, Berg D +3 more

Plain English
This study looked at guidelines created by the American Association of Neurological Surgeons for treating brain tumors over the past decade. It found that the guidelines for metastatic tumors had the most citations, with 26.1 per year, and received nearly 29,100 webpage visits. This matters because it shows how influential these guidelines are in shaping medical practices and spreading important information about brain tumor treatment. Who this helps: This helps doctors and medical professionals by providing them with trusted, research-backed guidelines for treating brain tumors.

PubMed

Initial biological classification of Lewy body diseases: No consensus on terminology.

2025

Alzheimer's & dementia : the journal of the Alzheimer's Association

Lang AE, Höglinger GU, Adler CH, Berg D, Klein C +4 more

PubMed

A Short Cognitive and Neuropsychiatric Assessment Scale for Progressive Supranuclear Palsy.

2025

Movement disorders clinical practice

Porsche S, Klietz M, Greten S, Piot IA, Jensen I +46 more

Plain English
This study focused on creating and testing a new assessment tool called the Short Cognitive and Neuropsychiatric (ShoCo) scale for patients with Progressive Supranuclear Palsy (PSP), a condition known to cause various cognitive and emotional difficulties. The scale scores range from 0 to 15, with higher scores indicating more severe deficits; patients scored an average of 5.9, and over a year, scores for patients with the more common form of PSP increased significantly. This tool is important because it provides a standardized way to measure the cognitive challenges faced by PSP patients, which can improve their care and help inform treatment options. Who this helps: This helps patients and doctors understand and track cognitive decline in individuals with Progressive Supranuclear Palsy.

PubMed

Ballet and how it can improve neuromuscular function with age.

2025

Journal of neurophysiology

Berg D, Hamernik W, Anderson A, Rochelle L, Blake B

Plain English
Researchers studied how ballet training affects balance and muscle function in older adults. They found that only 45% of dancers fell during a simulated balance test, compared to 82.6% of non-dancers. This shows that ballet can help older people maintain better stability and reduce the risk of falls as they age. Who this helps: This benefits older adults and those at risk of falling.

PubMed

Therapeutic modalities of deferiprone in Parkinson's disease: SKY and EMBARK studies.

2025

Journal of Parkinson's disease

Devos D, Rascol O, Meissner WG, Foubert-Samier A, Lewis S +27 more

Plain English
The research studied how well a drug called deferiprone could help people with early-stage Parkinson's disease (PD) reduce their motor disability. In two studies, SKY and EMBARK, it was found that while deferiprone didn't significantly improve motor function for patients already taking other medications (the dopaminergic-treated group), it did lead to worsening symptoms for those not yet on treatment, with a score increase of 8.3 points on a measure of motor function. This matters because it shows that deferiprone is not an effective treatment for motor symptoms in these patients and could make things worse for new patients. Who this helps: This helps patients with Parkinson's disease and their doctors in making informed treatment choices.

PubMed

Predictive potential of circular walking in prodromal Parkinson's disease.

2025

Journal of Parkinson's disease

Micó-Amigo ME, Kingma I, Heinzel S, Solbrig S, Hobert MA +7 more

Plain English
This study looked at how walking in circles might help detect early signs of Parkinson's disease in people who haven't been diagnosed yet. Researchers examined the walking patterns of 102 individuals, comparing 16 who developed Parkinson's disease later to 96 healthy individuals. They found that certain walking features, like low symmetry and rhythmicity, were linked to a higher chance of being diagnosed with Parkinson's, highlighting the potential for using simple walking tests to spot early motor changes. Who this helps: This benefits patients at risk of developing Parkinson's disease and their doctors.

PubMed

A network perspective on cognition in individuals with Parkinson's disease.

2025

Alzheimer's & dementia (Amsterdam, Netherlands)

Scharfenberg D, Kalbe E, Balzer-Geldsetzer M, Berg D, Hilker-Roggendorf R +13 more

Plain English
This study looked at how cognitive abilities are structured in people with Parkinson's disease by analyzing test scores from 698 patients. Researchers found that cognitive functions are closely linked and should be viewed as a single, connected network rather than separate categories; after reducing repetitive elements in tests, they identified one main dimension of cognitive ability. This matters because it shows that cognitive tests need to be updated to better reflect how these functions interact, making them more accurate for diagnosis and treatment. Who this helps: Patients with Parkinson's disease and their healthcare providers.

PubMed

Frequencies of Circulating Immune Cells in Patients with Parkinson's Disease: Correlation with MDS-UPDRS Scores.

2025

Journal of integrative neuroscience

Goldeck D, Oettinger L, Fülöp T, Schulte C, Hamprecht K +3 more

Plain English
This study looked at the immune cells in the blood of 35 patients with Parkinson's Disease (PD) compared to healthy individuals to see how they might relate to the disease. Researchers found that while most types of immune cells were similar between the two groups, PD patients had more myeloid-derived suppressor cells, and a specific type of monocyte was linked to more severe symptoms and longer disease duration. This is important because it highlights potential targets for new treatments aimed at reducing inflammation in PD. Who this helps: This helps patients with Parkinson's Disease and their doctors.

PubMed

Physical Activity and Enjoyment in Active Virtual Reality Games in Youth: Comparative Analysis of Gorilla Tag and Beat Saber.

2025

JMIR serious games

Boots B, Berg D, Hewitt E, Naugle K, Naugle K

Plain English
This study looked at how much physical activity and enjoyment young people experienced while playing two popular virtual reality (VR) games: Gorilla Tag and Beat Saber. The researchers found that players had a noticeably higher heart rate while playing Gorilla Tag compared to Beat Saber, with Gorilla Tag resulting in moderate activity and Beat Saber in light activity. Both games were rated as highly enjoyable, showing that young players can have fun while getting some exercise. Who this helps: This benefits young gamers and their parents, encouraging active play in a fun way.

PubMed

Motor and cognitive function after unipolar depressive episodes: a 6 years longitudinal observational study.

2025

Frontiers in psychology

Straub S, Hobert MA, Emmert K, Hansen C, Elshehabi M +7 more

Plain English
This study examined the effects of previous unipolar depression on cognitive and motor skills over six years in older adults. Researchers looked at 401 healthy adults aged 50 to 80 and found that those with a history of depression walked slower than those without, but their motor and cognitive skills did not decline further over time. This is important because it suggests that while past depression may affect walking speed, it may not be a reliable sign of future neurodegenerative diseases. Who this helps: This research helps doctors understand the long-term effects of depression on physical health in older patients.

PubMed

The prodromal individuals' perspective on active recruitment for early detection of α-synucleinopathies.

2025

NPJ Parkinson's disease

Röttgen S, Schaeffer E, Rogge A, Hartung R, Kufer K +4 more

Plain English
This study looked at how people with a sleep disorder called isolated REM sleep behavior disorder (iRBD) feel about being actively recruited for early detection of a brain disease linked to Parkinson's. Out of 99 invited individuals, 75 answered a survey; while over half found the risk information burdensome, most (96.2%) thought the recruitment method was appropriate and would participate again. The findings are important because they show that these individuals are willing to help research that could lead to new treatments. Who this helps: This helps patients with iRBD and potentially others at risk for related brain diseases.

PubMed

Multidisciplinary Guidance to Care for Persons With Xylazine-Associated Wounds.

2025

Open forum infectious diseases

Yang WT, Meisner JA, Maguire C, Dyer KE, McFadden R +8 more

Plain English
This study looked at wounds caused by xylazine, a drug that is increasingly mixed into illicit opioids and often leads to chronic infections in limbs. Researchers found that effective treatment for these wounds requires a team approach, including addiction support and specific antibiotics, while avoiding certain aggressive treatments that could worsen the condition. This is important because these wounds can be difficult to treat and pose serious health risks, highlighting the need for comprehensive care strategies. Who this helps: This helps patients with xylazine-related wounds and healthcare providers treating them.

PubMed

Tackling gender in progressive supranuclear palsy: Male patients present more apathy.

2025

Journal of Parkinson's disease

Ye L, Greten S, Wilkens I, Wegner F, Krey L +24 more

Plain English
This study looked at how gender affects symptoms in patients with progressive supranuclear palsy (PSP) by analyzing data from 191 men and 157 women. Researchers found that while men and women had similar motor skills and cognitive abilities, men experienced higher levels of apathy, which were notably significant. This matters because recognizing these differences can improve treatment and support for patients based on their gender. Who this helps: This helps doctors and caregivers understand how PSP may affect male patients differently, allowing for better care and support.

PubMed

Phase I/II Study of Subasumstat (TAK-981) in Combination With Rituximab in Relapsed/Refractory Non-Hodgkin Lymphoma.

2025

Clinical lymphoma, myeloma & leukemia

Assouline SE, Mehta A, Hanel W, Doucet S, Johnston PB +8 more

Plain English
This study looked at a new treatment called subasumstat combined with rituximab for patients with a type of cancer called non-Hodgkin lymphoma that had come back after previous treatments. Out of 29 patients receiving the new treatment, about 27.6% saw positive results, including two patients experiencing complete cancer remission. The combination showed a good safety profile, with mostly mild side effects similar to flu symptoms. Who this helps: This benefits patients with relapsed or hard-to-treat non-Hodgkin lymphoma.

PubMed

An Organizational Psychology Approach to Understanding Overuse in Pediatric Hospital Medicine.

2025

Hospital pediatrics

Yankova L, Sachdev M, Butala N, Allotta A, Osborn R +2 more

Plain English
The study examined why doctors in pediatric hospitals often provide unnecessary treatments, which costs the healthcare system $27 million each year and can harm patients both physically and emotionally. Researchers interviewed 16 pediatric hospitalists and identified five key influences on overuse: fear among doctors, the need for positive relationships, peer pressure, past experiences with parents and consultants, and institutional demands. Addressing these complex issues is crucial to improving patient care and reducing unnecessary treatments. Who this helps: This benefits patients and healthcare providers.

PubMed

Neurofilament Light Chain in Serum and CSF as a Potential Biomarker for Primary Angiitis of the Central Nervous System.

2025

Cells

Krüger C, Pinnschmidt H, Wilmes M, Dargvainiene J, Leypoldt F +4 more

Plain English
This study looked at a potential new way to diagnose a rare condition called primary angiitis of the central nervous system (PACNS) by measuring levels of a protein called neurofilament light chain (NfL) in the blood and spinal fluid of patients. Researchers found that patients with active PACNS had much higher NfL levels (average of 45.77 pg/mL in blood and 4914.58 pg/mL in spinal fluid) compared to those in remission or healthy controls. This matters because using NfL as a biomarker could improve diagnosis and understanding of PACNS, especially in younger patients. Who this helps: Patients with PACNS and their doctors.

PubMed

Work-related stressful events and burnout experienced by residents and specialists in German neurology: prevalence, causes, and coping strategies derived from a nationwide survey.

2025

Neurological research and practice

Piel JHA, Biesalski AS, Wolke R, Rogge A, Topka H +4 more

Plain English
This study looked at the burnout levels among neurology residents and specialists in Germany, finding that many experience high levels of stress from various work-related events, especially during emergencies. About 30% of participants considered changing jobs, while 10% thought about leaving the field entirely, indicating serious dissatisfaction. The study emphasizes the urgent need for better support and coping strategies in the workplace to help reduce burnout, particularly for healthcare workers facing high-stress situations. Who this helps: This helps healthcare professionals, especially those in neurology, by highlighting the need for better support systems to reduce burnout.

PubMed

Filamin A in the ovary: a mediator of granulosa cell functions.

2025

Reproduction & fertility

Jiang Y, Caban KM, Stöckl JB, Fröhlich T, Dissen GA +5 more

Plain English
This study looked at a protein called filamin A (FLNA) in the ovaries, specifically focusing on its role in granulosa cells, which help produce hormones and support the development of eggs. Researchers found that FLNA is important for maintaining the structure and functioning of these cells; when they reduced FLNA levels, it caused the cells to grow larger and change their shape, suggesting FLNA influences hormone production as well. Understanding how FLNA works in the ovaries is crucial since it may help improve treatments for fertility issues. Who this helps: This helps patients seeking fertility treatments and doctors aiming to enhance reproductive health.

PubMed

Progression to Parkinson's dementia is not modulated by genetic risk variants for Alzheimer's or Parkinson's disease.

2025

Journal of Parkinson's disease

Parveen K, Ross JA, van der Wurp H, Balzer-Geldsetzer M, Berg D +18 more

Plain English
This study looked at whether specific genetic factors related to Alzheimer's or Parkinson's disease affect how quickly patients with mild cognitive impairment from Parkinson's disease develop dementia. The researchers found that these genetic markers did not influence the progression to dementia in Parkinson's patients at all. This is important because it shows that genetics may not play a role in this particular aspect of disease progression, which could guide future research and treatment approaches. Who this helps: This helps doctors and researchers who are studying cognitive decline in Parkinson's patients.

PubMed

Electrophysiological Evidence for Impaired Central Pain Modulation in Parkinson's Disease.

2025

Movement disorders : official journal of the Movement Disorder Society

Kersebaum D, Lassen J, Forstenpointner J, Sendel M, Fabig SC +6 more

Plain English
This study looked at how people with Parkinson's disease (PD) process pain compared to those without it. Researchers tested 41 PD patients and found that they had a significantly reduced ability to adapt to painful stimuli, measured through a specific method called the laser-evoked potential (LEP) habituation. Specifically, this means that their brains did not reduce the response to pain as much as the brains of 24 healthy individuals; this impairment occurred regardless of the level of pain the patients reported feeling. Who this helps: This research benefits patients with Parkinson's disease by potentially improving their pain management.

PubMed

Differences in intestinal microbiota in Parkinson's disease and isolated REM sleep behavior disorder.

2025

Journal of Parkinson's disease

Troci A, Haas J, Weiß A, Heinzel S, Franke A +3 more

Plain English
This study looked at the gut bacteria of people with Parkinson's disease (PD) and those with isolated REM sleep behavior disorder (iRBD) compared to healthy individuals. Researchers found that both PD and iRBD patients had significant differences in their gut bacteria, showing more harmful bacteria and fewer beneficial bacteria that help produce short-chain fatty acids. These findings are important because they suggest that changes in gut bacteria might play a role in the development of Parkinson's disease. Who this helps: This helps patients at risk for Parkinson's disease and their doctors.

PubMed

The Oldenburg Hearing Health Record (OHHR).

2025

Scientific data

Jafri S, Berg D, Buhl M, Vormann M, Saak S +4 more

Plain English
The study focused on developing the Oldenburg Hearing Health Record (OHHR) to better understand hearing health by combining both objective tests and personal experiences. It involved 581 adults, aged 18 to 86, with varying levels of hearing loss. The OHHR provides important information like hearing tests and personal reports on difficulties, which helps improve personalized hearing care and enhance quality of life for patients. Who this helps: This benefits patients with hearing loss and healthcare providers involved in their care.

PubMed

Depending on intensity, exercise improved or worsened pathology in a model of prodromal Parkinson's disease.

2025

NPJ Parkinson's disease

Baldauf L, Feja M, Stanojlovic M, Strowig T, Visscher C +4 more

Plain English
This study looked at how different levels of exercise affect early signs of Parkinson's disease in mice. The researchers found that moderate exercise improved movement and coordination, while intense exercise also reduced anxiety and prevented some brain changes associated with Parkinson's. However, intensive exercise increased certain brain cell activity that could be concerning. Who this helps: Patients in the early stages of Parkinson's disease who are considering exercise as part of their treatment plan.

PubMed

Evaluation of an antibody panel for alpha-synuclein detection in FFPE rectal biopsies in Parkinson's disease.

2025

IBRO neuroscience reports

Schröder K, Kintrup C, Kulcsárová K, Heinzel S, Kluge A +9 more

Plain English
This study looked at how well certain antibodies can identify a protein called alpha-synuclein in rectal tissue samples from people with Parkinson's disease and healthy individuals. Researchers found that while the antibodies effectively detected alpha-synuclein in brain tissues, they showed no significant differences in rectal tissues between 24 Parkinson's patients and 20 healthy controls, indicating that these tests may not useful for diagnosing Parkinson's through rectal biopsies. This is important because better detection methods could help in understanding and diagnosing Parkinson's disease. Who this helps: Patients and doctors looking for new ways to diagnose Parkinson's disease.

PubMed

[Effects of massage in critically ill patients with pusher syndrome : Randomized controlled mixed-methods study protocol].

2025

Medizinische Klinik, Intensivmedizin und Notfallmedizin

Schmidt-Maciejewski B, Nydahl P, Richter MT, Trigui N, Berg D

Plain English
This study focuses on patients who have experienced a stroke and developed a complication called pusher syndrome (PS), which affects their sense of balance. Researchers are testing if a specific type of massage can help improve this balance perception when compared to standard care. If successful, the massage technique could lead to better outcomes for these patients, enhancing their ability to sit upright and recover. Who this helps: This benefits stroke patients dealing with pusher syndrome and their healthcare providers.

PubMed

Switching from alteplase to tenecteplase for stroke thrombolysis: short-term effects on treatment metrics and early functional outcomes.

2025

BMC neurology

Seiler A, Ingwersen L, Larsen N, Jansen O, Berg D +1 more

Plain English
This study looked at how switching from a medication called alteplase to another called tenecteplase affects stroke treatment. Researchers found that treating patients with tenecteplase led to faster treatment times, reducing the time from arrival to treatment from 28 minutes with alteplase to 23 minutes with tenecteplase. While short-term outcomes like recovery and risks of complications were similar between the two drugs, there were more instances of brain bleeding and deaths in the tenecteplase group. Who this helps: This benefits patients experiencing acute ischemic strokes by potentially reducing wait times for treatment.

PubMed

Detecting Misfolded α-Synuclein in Blood Years before the Diagnosis of Parkinson's Disease.

2024

Movement disorders : official journal of the Movement Disorder Society

Kluge A, Schaeffer E, Bunk J, Sommerauer M, Röttgen S +11 more

Plain English
This study looked at a blood test to identify early signs of Parkinson's disease (PD) in people even before they show symptoms. Researchers found that all patients diagnosed with PD had detectable markers in their blood up to 10 years before their diagnosis, and 30% of those with a related sleep disorder also tested positive. This matters because catching PD earlier could lead to treatments that slow down or change the disease's progression. Who this helps: This helps patients at risk for Parkinson's disease and their doctors.

PubMed

Association of Misfolded α-Synuclein Derived from Neuronal Exosomes in Blood with Parkinson's Disease Diagnosis and Duration.

2024

Journal of Parkinson's disease

Schaeffer E, Kluge A, Schulte C, Deuschle C, Bunk J +3 more

Plain English
This study looked at a protein called misfolded α-synuclein found in the blood of patients with Parkinson's disease (PD). Researchers found that nearly all (79 out of 80) PD patients tested positive for this protein, indicating a very high detection rate of 98.8%, while none of the healthy control participants did. Additionally, they discovered that as the duration of Parkinson's disease increased, the levels of this protein in the blood actually decreased, suggesting it could serve as a useful marker for tracking the disease's progression. Who this helps: Patients with Parkinson's disease and their doctors, as it may improve diagnosis and monitoring of the disease.

PubMed

Anticipating Tomorrow: Tailoring Parkinson's Symptomatic Therapy Using Predictors of Outcome.

2024

Movement disorders clinical practice

Postuma RB, Weintraub D, Simuni T, Rodríguez-Violante M, Leentjens AFG +8 more

Plain English
This research focused on how to improve treatment for people with Parkinson's disease by using knowledge about their specific disease characteristics and risks. The study found 19 recommendations that could help doctors choose the best treatments based on how a patient's symptoms and likelihood of future problems might develop. This matters because it encourages more personalized care, potentially leading to better symptom management for patients. Who this helps: Patients with Parkinson's disease.

PubMed

Elevated fecal calprotectin is associated with gut microbial dysbiosis, altered serum markers and clinical outcomes in older individuals.

2024

Scientific reports

Heinzel S, Jureczek J, Kainulainen V, Nieminen AI, Suenkel U +9 more

Plain English
This study looked at how elevated levels of fecal calprotectin, a marker of gut inflammation, relate to gut bacteria, inflammation in the blood, and health outcomes in older adults. Researchers analyzed data from 735 individuals, finding that those with high fecal calprotectin (over 100 µg/g) had more harmful gut bacteria and higher levels of certain inflammatory markers in their blood, as well as a greater likelihood of heart attacks and obesity. Understanding these links can help in managing gut inflammation and identifying at-risk older patients for better health interventions. Who this helps: This helps older patients and their healthcare providers by highlighting the importance of monitoring gut health.

PubMed

Concerns with the new biological research criteria for synucleinopathy - Authors' reply.

2024

The Lancet. Neurology

Lang AE, Höglinger GU, Adler CH, Berg D, Klein C +4 more

PubMed

Mid- and late-life lifestyle activities as main drivers of general and domain-specific cognitive reserve in individuals with Parkinson's disease: cross-sectional and longitudinal evidence from the LANDSCAPE study.

2024

Journal of neurology

Ophey A, Wirtz K, Wolfsgruber S, Balzer-Geldsetzer M, Berg D +15 more

Plain English
This study looked at how lifestyle activities in mid- and late-life affect brain function in people with Parkinson's disease. Researchers found that those who engaged in more complex activities during these life stages tended to perform better on cognitive tests. Specifically, individuals without cognitive impairment scored higher in these activities compared to those with mild cognitive issues (average of 4.6 compared to less, p=0.033). However, they also noted that even though these activities may be linked to better cognitive function, those with high engagement experienced a sharper decline in memory and overall thinking skills over time. Who this helps: This research helps patients with Parkinson's disease by highlighting the importance of staying active and engaged in complex activities as they age.

PubMed

Polysemous terms need context: A case of poorly differentiated spindle cell cutaneous squamous cell carcinoma.

2024

JAAD case reports

Read C, Borba A, Lantz D, Berg D

PubMed

Response to Viewpoint by Bernhardt et al.

2024

Movement disorders : official journal of the Movement Disorder Society

Kluge A, Schaeffer E, Berg D

PubMed

A Short Progressive Supranuclear Palsy Quality of Life Scale.

2024

Movement disorders : official journal of the Movement Disorder Society

Wilkens I, Stiel S, Bebermeier S, Schrag A, Greten S +27 more

Plain English
This study focused on creating a shorter questionnaire to assess the quality of life for patients with Progressive Supranuclear Palsy (PSP), which is a condition that affects movement and daily functioning. Researchers analyzed data from 245 PSP patients and developed a new 12-item questionnaire called the PSP-ShoQoL, which measures both mental and physical health. This shorter scale proved to be effective in capturing changes in quality of life over time, making it easier for doctors to use in both research and regular check-ups. Who this helps: This benefits patients with PSP and their doctors by making quality of life assessments quicker and more manageable.

PubMed

International Parkinson and Movement Disorder Society Viewpoint on Biological Frameworks of Parkinson's Disease: Current Status and Future Directions.

2024

Movement disorders : official journal of the Movement Disorder Society

Kalia LV, Berg D, Kordower JH, Shannon KM, Taylor JP +7 more

PubMed

Introduction: The Earliest Phase of Parkinson's Disease: Possibilities for Detection and Intervention.

2024

Journal of Parkinson's disease

Berg D, Bloem BR, Kalia LV, Postuma RB

PubMed

Insular monoaminergic deficits in prodromal α-synucleinopathies.

2024

Annals of clinical and translational neurology

Pilotto A, Galli A, Zatti C, Placidi F, Izzi F +19 more

Plain English
This study looked at patients with potential early signs of brain diseases related to a protein called alpha-synuclein, including those with a condition called isolated REM sleep behavior disorder (iRBD), Parkinson's disease (PD), and dementia with Lewy bodies (DLB). Researchers tracked 184 people and found that those with iRBD who had specific changes in brain activity were at a threefold higher risk of developing PD or DLB later on. These findings help identify patients who might need closer monitoring and targeted treatments earlier in the disease process. Who this helps: Patients at risk of developing Parkinson's disease or dementia, as well as their doctors and caregivers.

PubMed

Machine learning-based personalized composite score dissects risk and protective factors for cognitive and motor function in older participants.

2024

Frontiers in aging neuroscience

Schalkamp AK, Lerche S, Wurster I, Roeben B, Zimmermann M +7 more

Plain English
This study looked at how different factors influence cognitive and motor skills in older adults, using a new machine learning model that combines various data points like genetics, lifestyle, and health information into a single score. The findings showed that this score could predict cognitive and motor abilities nearly as accurately as more traditional methods, with exercise identified as a significant factor that can be changed to support healthier aging. This matters because it helps pinpoint what aspects of a person's life can be targeted to improve their quality of life as they age. Who this helps: This helps older adults and healthcare providers seeking to enhance healthy aging.

PubMed

Developing CLOUT: A Longitudinal, Cross-Program Chief Resident Curriculum to Increase Psychological Safety in the Clinical Learning Environment.

2024

Academic medicine : journal of the Association of American Medical Colleges

Dunne D, Asnes A, Berg D, Chen A, Dewey J +3 more

Plain English
This study focused on improving the workplace environment for medical trainees by training chief residents to foster psychological safety. A total of 66 chief residents participated in workshops that enhanced their skills in handling mistreatment and bias, resulting in a 25% increase in their confidence to address these issues. This is important because a safer learning environment helps trainees perform better and feel more supported during their education. Who this helps: This benefits medical trainees and chief residents by creating a more supportive learning atmosphere.

PubMed

Phase 1b study of the anti-CD38 antibody mezagitamab in patients with relapsed/refractory multiple myeloma.

2024

Blood neoplasia

Krishnan AY, Patel KK, Mohan M, Jagannath S, Niesvizky R +6 more

Plain English
This study looked at the safety and effectiveness of mezagitamab, a new treatment for patients with a type of cancer called relapsed/refractory multiple myeloma. Out of 50 patients, those receiving a specific dose of 600 mg showed a response rate of 47%, with an average treatment effect lasting about 22 months. This research is important because it shows that mezagitamab can provide meaningful benefits, similar to other treatments available for this hard-to-treat cancer. Who this helps: This benefits patients with relapsed/refractory multiple myeloma.

PubMed

Frequent Co-Authors

Eva Schaeffer Walter Maetzler Sebastian Heinzel Kathrin Brockmann Claudia Trenkwalder Jan Kassubek Anna-Katharina von Thaler Steffen Paschen Günter U Höglinger Jörg B Schulz

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.